Back to search
FDAFDA · Food and drugs·Recall number D-0257-2019

Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals) 100 mg, packaged in a) 100-capsule bottles (NDC 0185-0122-01); and b) 1000-capsule bottles, (NDC 0185-0122-10); Rx Only, Distributed by Sandoz Inc. Princeton, NJ 08540

Published November 21, 2018 · Recall initiated: November 2, 2018

Summary

FDA records drug Class III recall D-0257-2019, published November 21, 2018 and initiated November 2, 2018. Recalling firm: Sandoz Inc; Status: Terminated; Reported quantity: 14366 bottles; Lot: Lots: a) JB4952, JA7322 Exp. 03/2020; b) JA7324, Exp.03/2020. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Cross Contamination with Other Products

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)
Manufacturer
Sandoz Inc
Distributor
Nationwide within the United States
UPC
0301850122011
Lot
Lots: a) JB4952, JA7322 Exp. 03/2020; b) JA7324, Exp.03/2020
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals) 100 mg, packaged in a) 100-capsule bottles (NDC 0185-0122-01); and b) 1000-capsule bottles, (NDC 0185-0122-10); Rx Only, Distributed by Sandoz Inc. Princeton, NJ 08540 recalled?

Yes. FDA published recall D-0257-2019 on November 21, 2018. Reported hazard: Cross Contamination with Other Products

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS). UPC: 0301850122011.